1. Home
  2. ABEO vs XRPN Comparison

ABEO vs XRPN Comparison

Compare ABEO & XRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$4.76

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Logo Armada Acquisition Corp. II Class A Ordinary Shares

XRPN

Armada Acquisition Corp. II Class A Ordinary Shares

N/A

Current Price

$10.32

Market Cap

324.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ABEO
XRPN
Founded
1974
2024
Country
United States
United States
Employees
N/A
2
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
280.2M
324.7M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ABEO
XRPN
Price
$4.76
$10.32
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
1.4M
132.5K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
165.16
N/A
EPS
1.01
N/A
Revenue
$2,998,000.00
N/A
Revenue This Year
$1,276.65
N/A
Revenue Next Year
$112.53
N/A
P/E Ratio
$4.77
$72.74
Revenue Growth
258.18
N/A
52 Week Low
$3.93
$10.10
52 Week High
$7.54
$10.35

Technical Indicators

Market Signals
Indicator
ABEO
XRPN
Relative Strength Index (RSI) 51.45 58.78
Support Level $4.53 $10.26
Resistance Level $5.62 N/A
Average True Range (ATR) 0.20 0.02
MACD 0.04 -0.00
Stochastic Oscillator 71.53 85.57

Price Performance

Historical Comparison
ABEO
XRPN

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About XRPN Armada Acquisition Corp. II Class A Ordinary Shares

Armada Acquisition Corp II is a blank check company.

Share on Social Networks: